309 related articles for article (PubMed ID: 27540710)
21. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease.
Beigel F; Löhr B; Laubender RP; Tillack C; Schnitzler F; Breiteneicher S; Weidinger M; Göke B; Seiderer J; Ochsenkühn T; Brand S
Digestion; 2012; 85(1):47-54. PubMed ID: 22179489
[TBL] [Abstract][Full Text] [Related]
22. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD.
Lee T; Clavel T; Smirnov K; Schmidt A; Lagkouvardos I; Walker A; Lucio M; Michalke B; Schmitt-Kopplin P; Fedorak R; Haller D
Gut; 2017 May; 66(5):863-871. PubMed ID: 26848182
[TBL] [Abstract][Full Text] [Related]
23. Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?
Stancu S; Bârsan L; Stanciu A; Mircescu G
Clin J Am Soc Nephrol; 2010 Mar; 5(3):409-16. PubMed ID: 20019121
[TBL] [Abstract][Full Text] [Related]
24. High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23.
Dahlerup JF; Jacobsen BA; van der Woude J; Bark LÅ; Thomsen LL; Lindgren S
Scand J Gastroenterol; 2016 Nov; 51(11):1332-8. PubMed ID: 27326766
[TBL] [Abstract][Full Text] [Related]
25. Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency.
Bokemeyer B; Krummenerl A; Maaser C; Howaldt S; Mroß M; Mallard N
Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):229-238. PubMed ID: 27101422
[TBL] [Abstract][Full Text] [Related]
26. Is there any role of intravenous iron for the treatment of anemia in cancer?
Gemici C; Yetmen O; Yaprak G; Ozden S; Tepetam H; Ozyurt H; Mayadagli A
BMC Cancer; 2016 Aug; 16(1):661. PubMed ID: 27542823
[TBL] [Abstract][Full Text] [Related]
27. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis.
Lee TW; Kolber MR; Fedorak RN; van Zanten SV
J Crohns Colitis; 2012 Apr; 6(3):267-75. PubMed ID: 22405161
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
Prats M; Font R; García C; Muñoz-Cortés M; Cabré C; Jariod M; Romeu M; Giralt M; Martinez-Vea A
Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014
[TBL] [Abstract][Full Text] [Related]
29. A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
Derman R; Roman E; Modiano MR; Achebe MM; Thomsen LL; Auerbach M
Am J Hematol; 2017 Mar; 92(3):286-291. PubMed ID: 28052413
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of intravenous ascorbic acid versus intravenous iron for functional iron deficiency in hemodialysis patients].
Ogi M; Horiuchi T; Abe R; Wakabayashi M; Wakabayashi T
Nihon Jinzo Gakkai Shi; 2004; 46(8):804-9. PubMed ID: 15645737
[TBL] [Abstract][Full Text] [Related]
31. Parenteral iron sucrose in iron deficiency anaemia of paediatric chronic kidney disease.
Moorani KN; Asim S
J Ayub Med Coll Abbottabad; 2011; 23(3):47-50. PubMed ID: 23272434
[TBL] [Abstract][Full Text] [Related]
32. Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose.
Grim K; Lee B; Sung AY; Kotagal S
Sleep Med; 2013 Nov; 14(11):1100-4. PubMed ID: 23993871
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.
Charytan C; Levin N; Al-Saloum M; Hafeez T; Gagnon S; Van Wyck DB
Am J Kidney Dis; 2001 Feb; 37(2):300-7. PubMed ID: 11157370
[TBL] [Abstract][Full Text] [Related]
34. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route.
Bayoumeu F; Subiran-Buisset C; Baka NE; Legagneur H; Monnier-Barbarino P; Laxenaire MC
Am J Obstet Gynecol; 2002 Mar; 186(3):518-22. PubMed ID: 11904617
[TBL] [Abstract][Full Text] [Related]
35. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia.
Bregman DB; Morris D; Koch TA; He A; Goodnough LT
Am J Hematol; 2013 Feb; 88(2):97-101. PubMed ID: 23335357
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea.
Han YM; Yoon H; Shin CM; Koh SJ; Im JP; Kim BG; Kim JS; Jung HC
Gut Liver; 2016 Jul; 10(4):562-8. PubMed ID: 27021505
[TBL] [Abstract][Full Text] [Related]
37. Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial.
El Amrousy D; El-Afify D; Elsawy A; Elsheikh M; Donia A; Nassar M
Pediatr Res; 2022 Sep; 92(3):762-766. PubMed ID: 35681097
[TBL] [Abstract][Full Text] [Related]
38. Intravenous Iron Sucrose versus Oral Iron in the Treatment of Pregnancy with Iron Deficiency Anaemia: A Systematic Review.
Shi Q; Leng W; Wazir R; Li J; Yao Q; Mi C; Yang J; Xing A
Gynecol Obstet Invest; 2015; 80(3):170-8. PubMed ID: 25824489
[TBL] [Abstract][Full Text] [Related]
39. Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK.
Pollock RF; Muduma G
Expert Opin Drug Deliv; 2017 Dec; 14(12):1439-1446. PubMed ID: 29032713
[TBL] [Abstract][Full Text] [Related]
40. Improvement of Health-Related Quality of Life in Children with Inflammatory Bowel Disease Receiving Routine Intravenous Iron Supplementation.
Danko I; Weidkamp M; Eickhoff JC
J Pediatr Pharmacol Ther; 2019; 24(6):517-527. PubMed ID: 31719814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
